JSLGX | JULGX | JSLGX / JULGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 13 years | - |
Gain YTD | 13.205 | 13.432 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.61B | 8.61B | 100% |
Annual Yield % from dividends | 1.74 | 1.97 | 88% |
Returns for 1 year | 9.47 | 9.68 | 98% |
Returns for 3 years | -13.84 | -13.44 | 103% |
Returns for 5 years | -1.09 | -0.27 | 399% |
Returns for 10 years | 1.20 | 2.82 | 43% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CLTCX | 14.70 | 0.12 | +0.82% |
Catalyst/Lyons Tactical Allocation C | |||
VASVX | 27.22 | 0.16 | +0.59% |
Vanguard Selected Value Inv | |||
FBTTX | 26.89 | 0.09 | +0.34% |
Fidelity Advisor Biotechnology M | |||
NBNAX | 12.96 | 0.01 | +0.08% |
Neuberger Berman International Sel A | |||
MFVSX | 16.97 | N/A | N/A |
MassMutual Equity Opports R5 |